AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The transcription factor CCAAT/enhancer binding protein alpha, or C/EBPalpha, encoded by the CEBPA gene, is crucial for the differentiation of granulocytes. Conditional expression of C/EBPalpha triggers neutrophilic differentiation, and Cebpa knockout mice exhibit an early block in maturation. Dominant-negative mutations of CEBPA have been found in some patients with acute myeloid leukemia (AML), but not in AML with the t(8;21) translocation which gives rise to the fusion gene RUNX1-CBF2T1 (also known as AML1-ETO) encoding the AML1-ETO fusion protein. RUNX1-CBF2T1 positive-AML blasts had eight-fold lower CEBPA RNA levels and undetectable C/EBPalpha protein levels compared with other subgroups of AML patients. Conditional expression of RUNX1-CBF2T1 in U937 cells downregulated CEBPA mRNA, protein and DNA binding activity. AML1-ETO appears to suppress C/EBPalpha expression indirectly by inhibiting positive autoregulation of the CEBPA promoter. Conditional expression of C/EBPalpha in AML1-ETO-positive Kasumi-1 cells results in neutrophilic differentiation. We suggest that restoring C/EBPalpha expression will have therapeutic implications in RUNX1-CBF2T1-positive leukemias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and abolishes C/EBP 𝛂 expression. 54”
From RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements. (2003) · cites this paper as [54]
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“The U937T cell line in which U937 cells were stably transfected with the tetracycline transactivator (tTA) under the control of a tetracycline responsive elemen”
BackgroundEstablishment and characterization of a human histiocytic lymphoma cell line (U‐937)
Sundström, C., & Nilsson, K. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170504 · Cited by 2,407
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Cao, Z., Umek, R. M., & McKnight, S. L. (1991) · Genes & Development · doi:10.1101/gad.5.9.1538 · Cited by 1,663
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Luciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910
Self-citationPabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901 · cited 1×
“a the abnormalities were one del (9)(q22;q34); one t(6;9); one t(10;21)(p11;q22); one 8;one 14; and one complex aberrant karyotype.”
BackgroundSelf-citationMiyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872
Cited by
Items 401–462 of 462
Lineage-Specific Transcription Factor Aberrations in AML
Mueller, B. U., & Pabst, T. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-69259-3_7 · Cited by 3
Self-citationChromosomal Translocations in Leukaemia: Emerging Networks
Bohlander, S. K. (2004) · Springer eBooks · doi:10.1007/978-94-017-1033-6_15 · Cited by 1
Clinical and Biological Relevance of Gene Expression Profiling in Acute Myeloid Leukemia
Alicja, M., & Alcalay, M. (2012) · InTech eBooks · doi:10.5772/27519 · Cited by 1
“For example, expression of AML fusion proteins such as AML1/ETO, PML/RAR, and PLZF/RAR in the U937 hematopoietic cell line resulted in deregulation of a large set of common targets (Alcalay et al. 2003).”
InfluentialTranscriptional Repression of C/EBPα by Histone Deacetylases in Acute Myeloid Leukemia
Steffen, B., Ruthardt, M., Becker, K., Klümpen, S., Möller, M., Berdel, W. E., Serve, H. L., & Müller‐Tidow, C. (2003) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-59358-1_10 · Cited by 1
CEBPA (CCAAT/enhancer binding protein (C/EBP), alpha)
Tian, T., & Graf, T. (2015) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/56435 · Cited by 2
The potential of a single enhancer
Heuston, E. F. (2016) · Blood · doi:10.1182/blood-2016-03-706218 · Cited by 1
“In particular, the RUNX1–RUNX1 translocated to 1 (RUNX1RUNX1T1, or AML1-ETO) fusion protein that results from the t(8;21) AML translocation constitutes an entire AML subgroup in which CEBPA expression is suppressed due to the mislocalization of the RUNX1 transcription factor.(4) The epigenetic regulation of CEBPA by R…”
BackgroundMicroRNAs and Cancer Connecting the Dots
Jayasena, S. D. (2009) · CRC Press eBooks · doi:10.1201/9781420008708.ch19 · Cited by 1
Biology of Chronic and Acute Myeloid Leukemia
Quintás‐Cardama, A., Cortes, J. E., & Kantarjian, H. M. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10028-7 · Cited by 1
Yoganarasimha, B., Chandramohan, V., Murthy, T. P. K., Gangadharappa, B. S., Siddaiah, G. B., & Makari, H. K. (2016) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2016.07.009 · Cited by 1
“Mutations in transcription factors that encode for myeloid differentiation can be found in patients with AML.(14) CCND1 binds and activates the G1 cyclindependent kinases CDK4 and CDK6.”
BackgroundRawat, V. P. S. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.6752 · Cited by 1
Mutations in human cancer: how close should we look?
Cammenga, J., & Nimer, S. D. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00174-6 · Cited by 1
Pramanik, K., Trüpschuch, S., Greiner, A., Ruthardt, M., Henschler, R., & Müller, A. M. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.09.014 · Cited by 1
“Analysis into the olecular mechanism of AML1-ETO (RUNX1-RUNX1T1) unction indicated that AML1-ETO interferes with the xpression of crucial myeloid differentiation factors such as CAAT/enhancer binding protein alpha (C/EBP ) [4] and he Ets family transcription factor PU.”
BackgroundInfluentialGene Therapy for Leukemia and Lymphoma
Huang, X., & Yang, Y. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-5698-9_5 · Cited by 1
Fliegauf, M., Burger, J. A., Claus, R., Stock, M., Otto, F., & Lübbert, M. (2003) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-59358-1_8 · Cited by 2
Coppersmith, H. J., Kim, H., & Klug, C. (2010) · Blood · doi:10.1182/blood.v116.21.4195.4195 · Cited by 1
The Role and Regulation of p21 in Myelopoiesis
Ghanem, L. R. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Studies on CEBPA mutations in acute myeloid leukaemia
Green, C. L. (2012) · UCL Discovery (University College London)
Genetic Modeling of Human Blood Cancers in Mice
Hu, Y., & Li, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9_2
“Recruitment of the AML1 complex to the enhancers of its target genes can be direct or cooperatively with other proteins (Pabst et al., 2001).”
BackgroundAnticancer Effects of Intermittent Hypoxia in Acute Myeloid Leukemia
Chen, G., & Liu, W. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2906-6_19 · Cited by 1
Genomic and Epigenomic Studies of Acute Myeloid Leukemia with CEBPA Abnormalities
Wouters, B. J. (2009) · EUR Research Repository (Erasmus University Rotterdam)
Satellite Symposia and Meet-the-Professor Sessions
Schmid, C., Schleuning, M., & Kolb, H.-J. (2006) · Annals of Hematology · doi:10.1007/s00277-005-0079-8
Characterisation of the leukaemia-associated ETO homologues
Lindberg, S. R. (2006) · Lund University Publications (Lund University)
The role of the leukemia-associated ETO homologue repressors in hematopoiesis
Olsson, A. (2006) · Lund University Publications (Lund University)
Aberrant Transcription Factors in AML
Friedman, A. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_2
Redirection of Oncoproteins to Kill Cancer Cells
Müller‐Tidow, C., Steffen, B., Berdel, W. E., & Serve, H. L. (2003) · Cell Cycle · doi:10.4161/cc.2.6.585
“4), Deutsche Krebshilfe (10-1530) and the IZKF (IKF3H4) at the University of”
BackgroundCEBPA (CCAAT enhancer binding protein alpha)
Smith, L. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38341
The Progress in Relationship between CCAAT/Enhancer Binding Proteins (C/EBPs) Family and Leukemia
Su, E.-Y., Bai, H., & Jiang, G. (2010) · International Conference on Bioinformatics and Biomedical Engineering · doi:10.1109/icbbe.2010.5516479
Cilloni, D., Carturan, S., Maffè, C., Messa, F., Arruga, F., Messa, E., Pradotto, M., Pautasso, M., Zanone, C., Fornaciari, P., et al. (2010) · Leukemia · doi:10.1038/leu.2009.207
Valk, J. M., Melnick, A. M., Langerak, A. W., Löwenberg, B., Fazzari, M. J., Greally, J. M., Figueroa, M. E., Wouters, B. J., Skrabanek, L. A., Li, Y., et al. (2009)
Pulikkan, J. A. (2008) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10298
Molecular Genetic Insights in Cytogenetically-Normal Pediatric Acute Myeloid Leukemia
Hollink, I. H. I. M. (2011) · EUR Research Repository (Erasmus University Rotterdam)
the t(8;21) Fusion Protein Neurofibromatosis-1 Tumor Suppressor by Transcriptional Repression of the
Hiebert, S. W., Gutmann, D. H., Delwel, R., Clapp, D. W., Gao, M., Khalaf, W. F., & van de Locht, L. T. (2014)
New mechanisms of androgen receptor signaling
Zhang, J. (2008) · OhioLink ETD Center (Ohio Library and Information Network)
Hiddemann, W. (2007)
Self-citationHiddemann, W. (2008)
Self-citationLoke, J. C. T., Ptasinska, A., Imperato, M. R., Assi, S. A., Cauchy, P., Cowell, I. G., Heidenreich, O. T., Raghavan, M., Delwel, R., Cockerill, P., et al. (2016) · Klinische Pädiatrie · doi:10.1055/s-0036-1582520
Vornlocher, H., Nordheim, A., Heidenreich, O. T., Krauter, J., Riehle, H., Hadwiger, P., John, M., & Heil, G. (2013)
[Reviews] Pathogenetic and clinical significance of genetic abnormalities in acute myeloid leukemia
Matsumura, I. (2010) · Institutional Repositories DataBase (IRDB)
Studies on the core binding factor complex in patients with acute myeloid leukaemia
Langabeer, S. E. (2002) · OpenGrey (Institut de l'Information Scientifique et Technique)
Kern, W., Haferlach, T., & Hiddemann, W. (2004) · Springer eBooks · doi:10.1007/978-3-662-06670-6_75 · Cited by 2
Self-citation(2003) · Elsevier eBooks · doi:10.1016/b978-012639881-6/50011-7
(2009) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2009-39-1-44
Recent applications of RNA interference (RNAi) in mammalian systems
Scherer, L. J., & Rossi, J. J. (2005) · Letters in Peptide Science · doi:10.1007/s10989-005-4924-3
Recent applications of RNA interference (RNAi) in mammalian systems
Scherer, L. J., & Rossi, J. J. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02484562
Bhavsar, S., Jain, S., Yatsenko, S. A., Surti, U., Swerdlow, S. H., & Aggarwal, N. (2022) · Research Square · doi:10.21203/rs.3.rs-2023169/v1
Germline Predisposition to MDS and AML
Khiami, M., & Włodarski, M. W. (2024) · Pediatric oncology · doi:10.1007/978-3-031-63366-9_3
Derevyanko, P. K., Swart, L. E., Casimiro, L. D. M., van den Brink, L. M., van Oort, A. T., Ashtiani, M., Zwaan, C. M., Krippner‐Heidenreich, A., Bonifer, C., Schiffelers, R. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.637937
“Repression of C/EBP α is associated with the differentiation block in t(8;21) AML 64 , and CEBPE is a direct target of RUNX1::RUNX1T1-mediated repression (Fig.”
In-depth analysis of tumor markers in leukemia
Hassou, N., Ahnyne, R., Boussettine, R., Berradi, H., & Ennaji, M. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30225-1.00009-9
The Functions and Regulatory Chemicals of Human Leucine Zipper Transcription Factors (LZ TFs)
Yang, H., Bi, S., Yu, B., Fang, P., & Wang, J. (2025) · 化学学报 · doi:10.6023/a25020042
Nibourel, O. (2010) · theses.fr (ABES) · doi:10.70675/a0f6af54zade8z452eza6efz3f822211d048
Détection des anomalies génétiques dans les LAL-T : de la biologie à la clinique
Abdelali, R. B. (2011) · theses.fr (ABES) · doi:10.70675/90f2a16fz3cdez41f5z8dfez0848b91eb777
Xuelu, P. E. N. G., Gu, R., Wang, T., Jiang, C., Xing, H., Meng, J., Wen, T., Liu, J., Wang, J., & Xu, H. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01785-8 · Cited by 1
Xuelu, P. E. N. G., Gu, R., Wang, T., Jiang, C., Xing, H., Meng, J., Wen, T., Wang, J., Liu, J., & Xu, H. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103260
“…translocation generates the well-known fusion protein AML1-ETO, which plays a pivotal role in the blockade of multiple lineage differentiation, including granulocytic [7,8], megakaryocytic and erythroid [9,10], as well as in leukemogenesis, disease progression and drug resistance development [11].”
Azevedo, A., Leckenby, A., Nicholson, R. I., Menezes, A. C., Davies, S., Gilkes, A., Baker, S., Toghill, R., McCracken, E., Pierce, A., et al. (2026) · Blood Neoplasia · doi:10.1016/j.bneo.2026.100259
Li, S., He, S., Su, Y., Wang, L., Wang, Y., Xu, Y., Li, Y., & Zhou, J. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2608310123
Tónix-Ramirez, N. A., Sánchez-Medina, E., Muñóz-Perez, L. E., Ramos, R. H., Guevara‐Espejel, C., Bautista, E., & Osorio-Antonio, F. (2026) · Case Reports in Hematology · doi:10.1155/crh/8189036
The molecular mechanism of the aberrant expression of the B-cell specific PAX5 gene in t(8;21) AML
Ray, D. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham)
Laslo, P., & Stopka, T. (2014) · Epigenetics and human health · doi:10.1007/978-3-642-45198-0_9
Metadata
- Authors
- Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G.
- Affiliations
- Harvard University (US)
- Helmholtz Munich (DE)
- Scripps Research Institute (US)
- Corresponding author
- Tenen, Daniel G.
- Venue
- Nature Medicine
- Published
- 2001-04
- Volume
- 7
- Issue
- 4
- Pages
- 444-451
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1489323849
- Semantic Scholar
- 0dc02b7bfde7f6d2b964fdb5715593ac0bec54f2
- Cited by
- 463
- References
- 45
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 12 · 2022: 4 · 2021: 16 · 2020: 8 · 2019: 13 · 2018: 9 · 2017: 14 · 2016: 10 · 2015: 13 · 2014: 7 · 2013: 18 · 2012: 18
- FWCI
- 15.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL056745, HL56745)
- National Cancer Institute (CA-72009, P01CA072009)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Keywords
- AML1-ETO, C/EBPα, CEBPA, acute myeloid leukemia, granulocytic differentiation, transcriptional repression, conditional gene expression, U937 cells, Kasumi-1 cells, therapeutic target
- MeSH terms
- RUNX1 Translocation Partner 1 Protein, Animals, Base Sequence, Cell Differentiation, Chromosomes, Human, Pair 21, Chromosomes, Human, Pair 8, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proto-Oncogene Proteins, RNA, Messenger, RNA, Neoplasm, Transcription Factors, Translocation, Genetic, Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, Down-Regulation, DNA Primers, CCAAT-Enhancer-Binding Protein-alpha, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.